SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000947871-24-000715
Filing Date
2024-08-22
Accepted
2024-08-22 16:53:06
Documents
5
Period of Report
2024-08-22

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ss3778570_6k.htm 6-K 15475
2 MATERIAL CHANGE REPORT ss3778570_ex9901.htm EX-99.1 25036
3 ARRANGEMENT AGREEMENT ss3778570_ex9902.htm EX-99.2 465487
4 VOTING SUPPORT AGREEMENT (CANNELL) ss3778570_ex9903.htm EX-99.3 57376
5 FORM OF VOTING SUPPORT AGREEMENT (DS&OS) ss3778570_ex9904.htm EX-99.4 46854
  Complete submission text file 0000947871-24-000715.txt   611383
Mailing Address 919 11 AVENUE SW SUITE 300 CALGARY A0 T2R1P3
Business Address 919 11 AVENUE SW SUITE 300 CALGARY A0 T2R1P3 14039485227
SNDL Inc. (Filer) CIK: 0001766600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39005 | Film No.: 241232614
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)